CDKN1A and hepatocellular carcinoma: Furthermore, it has been demonstrated that the activation of ERK1/2 signaling pathway in HCC stabilizes the p21 protein by inhibiting p21 ubiquitination degradation, thereby inhibiting HCC cell proliferation [22,23].